OpenVSafe by OpenVAERS
Search V-safe

VG9-39767-35127

2 vaccinations 4 coded responses 19 check-ins 0 free-text entries 2 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
787 / TX
Registered
2023-02-13
Relationship
Child or adolescent in my care
Guardian
76R-55278-27813
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2023-02-13
    Registered in v-safe
  2. 2023-02-13
    Dose 1 — Pfizer-BioNTech
    Co-administered: Flu:Hepatitis B:Hib:Other:Rotavirus:Tetanus
  3. 2023-02-13
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Site: Swelling/hardness · Fever · Sleepiness
    Under 3 check-in
  4. 2023-02-15
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness, Loss of appetite
    Under 3 check-in
  5. 2023-02-16
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness, Loss of appetite
    Under 3 check-in
  6. 2023-02-17
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2023-02-18
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2023-02-19
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2023-02-20
    Survey response — day 7, dose 1, under 3
    MedDRA: Constipation — Feeling: Good
    MedDRA releases: 2024-11
  10. 2023-02-27
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2023-03-08
    Survey response — day 21, dose 1, under 3
    MedDRA: Ear infection, Nasopharyngitis, Office visit — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  12. 2023-03-08
    Report sent to call center — day 21, dose 1, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2023-03-09
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  14. 2023-03-13
    Dose 2 — Pfizer-BioNTech
    Co-administered: Flu
  15. 2023-03-13
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  16. 2023-03-17
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Redness · None
    Under 3 check-in
  17. 2023-03-19
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  18. 2023-03-20
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2023-03-27
    Survey response — day 14, dose 2, under 3
    MedDRA: Conjunctivitis, Ear infection, Office visit — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  20. 2023-03-27
    Report sent to call center — day 14, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2023-03-28
  22. 2023-04-03
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2023-04-10
    Survey response — day 28, dose 2, under 3
    MedDRA: Abdominal pain upper, Vomiting — Feeling: Fair
    MedDRA releases: 2024-11
  24. 2023-04-17
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2023-04-24
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  26. 2023-06-12
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12023-02-13Pfizer-BioNTech Flu:Hepatitis B:Hib:Other:Rotavirus:Tetanus
22023-03-13Pfizer-BioNTech Flu

Call center

ReportedOutcomeVAERS-related outcome
2023-03-08 Successful
2023-03-09
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-03-27 Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAbdominal pain upper · · ✓
SDConjunctivitis · · ✓
SDEar infection · · ✓
SDNasopharyngitis · · ✓
SDVomiting · · ✓
SROConstipation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release